Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.190 +0.010 (+0.12%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
Via AB Newswire
Exposures COVID-19
American Airlines, CAVA Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Smart Money Is Betting Big In NVAX Options
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Via Benzinga
Novavax Unusual Options Activity For May 23
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Vaccine Stocks Rallied This Week
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely? 
Via The Motley Fool
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress. 
Via InvestorPlace
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
Experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of Covid infections in the U.S. and experts believe its mutations have made the... 
Via Benzinga
Exposures COVID-19
3 Biotech Stocks to Buy Now: May 2024
As the biotech industry continues to rise in market prominence, investors should start considering what the best biotech stocks to buy are. 
Via InvestorPlace
Is Novavax Stock a Buy?
Can Novavax's stock continue soaring? 
Via The Motley Fool
Novavax's Options: A Look at What the Big Money is Thinking
Via Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Better Buy: Inovio Pharmaceuticals vs. Novavax
Both biotechs have been struggling for a while, but there might be some hope for them. 
Via The Motley Fool
3 Things You Need to Know If You Buy Novavax Today
The vaccine maker's recovery story is looking brighter. 
Via The Motley Fool
The $10 Stock Jackpot: 3 Speculative Plays That Could Double Overnight
These are the cheap speculative stocks to buy as they represent companies with average fundamentals, but impending business growth catalysts. 
Via InvestorPlace
Roaring Kitty’s Rally Cry: 3 Meme Stocks to Pounce On Now
Jump into action with NVAX, HOOD and WKHS as top meme stocks to buy, offering the chance to capitalize on short squeezes and momentum. 
Via InvestorPlace
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
From Shah Capital
Via GlobeNewswire
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The biotech still hasn't lost momentum. 
Via The Motley Fool
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
3 Must-Buy Meme Stocks When Prices Plunge
These are the meme stocks to buy on corrections as they represent companies with impending growth catalysts. 
Via InvestorPlace
Could Novavax Become the Next Moderna?
Sanofi believes in Novavax's vaccine strengths... 
Via The Motley Fool
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
This coronavirus vaccine maker entered the market behind rivals. 
Via The Motley Fool
Exposures COVID-19
Analyst Upgrades: 3 Stocks Getting the Nod From Pros Last Week
Explore key insights on stocks with analyst upgrades and their impact on market trends amid economic shifts. 
Via InvestorPlace
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy. 
Via The Motley Fool
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
These two healthcare stocks may be deeply undervalued. 
Via The Motley Fool
3 Stocks Under $2 That Can Trade in Double Digits by 2025
These stocks under $2 are likely to surge higher as they represent companies with impending growth catalysts. 
Via InvestorPlace
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.